| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-08-3728 |
| P698 | PubMed publication ID | 19223533 |
| P2093 | author name string | Hiroyuki Tanaka | |
| Hiroaki Kataoka | |||
| Haixia Cheng | |||
| Nobuyasu Takahashi | |||
| Tsuyoshi Fukushima | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1828-1835 | |
| P577 | publication date | 2009-02-17 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases | |
| P478 | volume | 69 |
| Q30496002 | A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk |
| Q37357076 | An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). |
| Q57484740 | Caveolin-1 and -2 regulate cell motility in castration-resistant prostate cancer |
| Q90141187 | Cell surface-anchored serine proteases in cancer progression and metastasis |
| Q39437208 | Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase |
| Q54222481 | Clinical implication of TMPRSS4 expression in human gallbladder cancer. |
| Q34238503 | Diversity of matriptase expression level and function in breast cancer. |
| Q34568589 | Endogenous expression of matriptase in neural progenitor cells promotes cell migration and neuron differentiation |
| Q38166588 | Epithelial-mesenchymal transition in pancreatic carcinoma |
| Q53075335 | Expression of matriptase correlates with tumour progression and clinical prognosis in oral squamous cell carcinoma. |
| Q34984574 | Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition |
| Q34704882 | Hepatic stellate cells secretes type I collagen to trigger epithelial mesenchymal transition of hepatoma cells. |
| Q39618840 | Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells. |
| Q55343941 | Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells. |
| Q86048023 | High expression level of TMPRSS4 predicts adverse outcomes of colorectal cancer patients |
| Q38771773 | Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer |
| Q39177327 | Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2. |
| Q34423998 | Loss of function of e-cadherin in embryonic stem cells and the relevance to models of tumorigenesis |
| Q39074016 | Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model |
| Q39409341 | Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness. |
| Q35696184 | Matriptase promotes inflammatory cell accumulation and progression of established epidermal tumors |
| Q47632003 | Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1. |
| Q38255480 | Mechanisms of hepatocyte growth factor activation in cancer tissues |
| Q37709042 | Membrane Proteins Involved in Epithelial-Mesenchymal Transition and Tumor Invasion: Studies on TMPRSS4 and TM4SF5. |
| Q36969010 | Membrane-anchored serine proteases in health and disease. |
| Q38575459 | Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity. |
| Q47157413 | Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma |
| Q47133508 | Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma |
| Q51221442 | Recombinant hepatocyte growth factor activator inhibitor 1: expression in Drosophila S2 cells, purification and crystallization. |
| Q34284285 | Role of emmprin in endometrial cancer |
| Q35105421 | Sj7170, a unique dual-function peptide with a specific α-chymotrypsin inhibitory activity and a potent tumor-activating effect from scorpion venom |
| Q35810625 | Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes |
| Q35823094 | Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis |
| Q37164922 | Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers. |
| Q28478908 | TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model |
| Q35652104 | TMPRSS4-dependent activation of the epithelial sodium channel requires cleavage of the γ-subunit distal to the furin cleavage site |
| Q42510397 | The cellular character of liquefaction degeneration in oral lichen planus and the role of interferon gamma |
| Q54415251 | The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer. |
| Q35915752 | ZEB1-responsive genes in non-small cell lung cancer |
| Q38670573 | miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer |
Search more.